| Symbol | Name | Last Close | Mkt Cap | DailyStocks' Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
|
Vote Now! Friday’s Close |
|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | $139.96 | $375.48B | N/A |
JNJ says no asbestos found in baby powder
https://seekingalpha.com/news/3523522-jnj-says-no-asbestos-found-in-baby-powder?source=feed_news_all
Dec 03, 2019 - Tests conducted by two third-party labs show asbestos was not present in the single bottle that the FDA's contracted lab tested, nor was it present in retained samples of the finished lot from which t
0
J&J's (JNJ) New Tests Reveal No Asbestos in Baby Powders
http://www.zacks.com/stock/news/653885/jjs-jnj-new-tests-reveal-no-asbestos-in-baby-powders?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-653885
Dec 04, 2019 - J&J (JNJ) says that two third-party labs conducted 155 tests on samples of its baby powders. All these tests confirm that the talc does not contain asbestos, a known carcinogen.
0
Dow Jones News: Johnson & Johnson Concludes Asbestos Investigation; Analyst Sees Upside for United Technologies
https://www.fool.com/investing/2019/12/04/dow-jones-news-johnson-johnson-concludes-asbestos.aspx?source=iedfolrf0000001
Dec 04, 2019 - J&J's baby powder is asbestos free, and United Technologies stock could rise another 16%.
0
3 Warren Buffett Dividend Stocks You Can Buy Right Now
https://www.fool.com/investing/2019/12/05/3-warren-buffett-dividend-stocks-you-can-buy-right.aspx?source=iedfolrf0000001
Dec 05, 2019 - Get paid like the famous investor with these relatively high-yield payers.
0
Glaxo Files NDA for Fostemsavir for Heavily Pre-Treated HIV
http://www.zacks.com/stock/news/657513/glaxo-files-nda-for-fostemsavir-for-heavily-pre-treated-hiv?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-657513
Dec 06, 2019 - Glaxo (GSK) submits a new drug application to the FDA for its first-in-class attachment inhibitor fostemsavir, which is being evaluated for the treatment of HIV-1 infection.
0
Amgen Gets FDA Approval for J&J/Merck's Remicade Biosimilar
http://www.zacks.com/stock/news/661958/amgen-gets-fda-approval-for-jj-mercks-remicade-biosimilar?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-661958
Dec 09, 2019 - FDA gives nod to Amgen's (AMGN) Avsola (ABP 710), a biosimilar of J&J's blockbuster rheumatoid arthritis drug, Remicade.
0
2 Healthcare Stocks I’d Buy Right Now
https://www.fool.com/investing/2019/12/16/2-healthcare-stocks-id-buy-right-now.aspx?source=iedfolrf0000001
Dec 16, 2019 - These two companies are industry leaders in their respective fields.
0
JNJ: Barclays ups to Overweight
https://www.briefing.com/in-depth-analysis/Content/Article?ArticleId=UD20191219073140
Dec 19, 2019 - Barclays issues rating change for JNJ
0
The Top Biotech Stocks to Watch Following ASH 2019
https://www.fool.com/investing/2019/12/19/the-top-biotech-stocks-to-watch-following-ash-2019.aspx?source=iedfolrf0000001
Dec 19, 2019 - The potential to reshape treatment of blood cancer and disorders could mean big bucks for these companies.
0
Bet on These 5 Low Leverage Stocks to Invest Judiciously
http://www.zacks.com/stock/news/690197/bet-on-these-5-low-leverage-stocks-to-invest-judiciously?cid=CS-ZC-FT-analyst_blog|rw-690197
Dec 27, 2019 - Debt level of a company is an important point of consideration while making an investment decision.
0
Page 1>